UBS Group’s Scienture Holdings SCNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $17.6K | Sell |
2,709
-728
| -21% | -$6.78K | ﹤0.01% | 8602 |
|
|
2026
Q2 | $30.1K | Sell |
3,437
-876
| -20% | -$8.32K | ﹤0.01% | 7891 |
|
|
2026
Q1 | $30.7K | Sell |
4,313
-4,525
| -51% | -$51.7K | ﹤0.01% | 7671 |
|
|
2025
Q4 | $113K | Buy |
8,838
+4,264
| +93% | +$74.9K | ﹤0.01% | 6854 |
|
|
2025
Q3 | $97.2K | Buy |
+4,574
| New | +$163K | ﹤0.01% | 7138 |
|
|
2025
Q2 | – | Sell |
-320
| Closed | -$11.5K | – | 11035 |
|
|
2025
Q1 | $11.5K | Buy |
320
+179
| +127% | +$14K | ﹤0.01% | 8546 |
|
|
2024
Q4 | $21.4K | Sell |
141
-14
| -9% | -$2.63K | ﹤0.01% | 7824 |
|
|
2024
Q3 | $29.4K | Buy |
+155
| New | +$39.5K | ﹤0.01% | 7141 |
|
|
2024
Q2 | – | Sell |
-10
| Closed | -$2.52K | – | 10241 |
|
|
2024
Q1 | $2.52K | Buy |
+10
| New | +$2.47K | ﹤0.01% | 7885 |
|
|
2023
Q3 | – | Sell |
-36
| Closed | -$11.7K | – | 10061 |
|
|
2023
Q2 | $11.7K | Buy |
+36
| New | +$5.05K | ﹤0.01% | 7097 |
|
|
2023
Q1 | – | Sell |
-30
| Closed | -$4.53K | – | 10545 |
|
|
2022
Q4 | $4.53K | Buy |
30
+20
| +200% | +$5.34K | ﹤0.01% | 9323 |
|
|
2022
Q3 | $4K | Buy |
10
+9
| +900% | +$4.77K | ﹤0.01% | 9412 |
|
|
2022
Q2 | $1K | Sell |
1
-7
| -88% | -$4.41K | ﹤0.01% | 9995 |
|
|
2022
Q1 | $9K | Buy |
+8
| New | +$6.2K | ﹤0.01% | 8573 |
|
|
2021
Q4 | – | Sell |
-14
| Closed | -$27K | – | 10813 |
|
|
2021
Q3 | $27K | Hold |
14
| – | – | ﹤0.01% | 6863 |
|
|
2021
Q2 | $24K | Buy |
14
+11
| +367% | +$17.6K | ﹤0.01% | 7159 |
|
|
2021
Q1 | $6K | Buy |
+3
| New | +$7.08K | ﹤0.01% | 8255 |
|
|
2020
Q3 | – | Sell |
-5
| Closed | -$10K | – | 8478 |
|
|
2020
Q2 | $10K | Buy |
+5
| New | +$11.6K | ﹤0.01% | 7036 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 8501 |
|
Other funds holding SCNX
UBS Group's SCNX Position: Q3 2026 in Review
UBS Group reduced its Scienture Holdings (SCNX) stake by 21% in Q3 2026, selling an estimated $6.78K and leaving 2,709 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #8602.
UBS Group first reported a position in SCNX in Q2 2020 and has held it in 18 quarters since. The position peaked at $113K in Q4 2025. 7 funds tracked by Wall St. Rank hold SCNX as of Q3 2026.
- UBS Group held 2,709 shares of Scienture Holdings worth $17.6K as of Q3 2026.
- UBS Group sold 728 Scienture Holdings shares in Q3 2026, an estimated $6.78K.
- Scienture Holdings made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8602 holding.
- UBS Group first reported a position in Scienture Holdings in Q2 2020 and has held it in 18 quarters since.
- UBS Group's Scienture Holdings position peaked at $113K in Q4 2025.
- 7 funds tracked by Wall St. Rank held Scienture Holdings as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.